Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing

J Immunol. 2004 Feb 1;172(3):1371-9. doi: 10.4049/jimmunol.172.3.1371.

Abstract

In the mouse, Bruton's tyrosine kinase (Btk) is essential for efficient developmental progression of CD43(+)CD2(-) large cycling into CD43(-)CD2(+) small resting pre-B cells in the bone marrow and of IgM(high) transitional type 2 B cells into IgM(low) mature B cells in the spleen. In this study, we show that the impaired induction of cell surface changes in Btk-deficient pre-B cells was still noticeable in kappa(+) immature B cells, but was largely corrected in lambda(+) immature B cells. As lambda gene rearrangements are programmed to follow kappa rearrangements and lambda expression is associated with receptor editing, we hypothesized that the transit time through the pre-B cell compartment or receptor editing may affect the extent of the cellular maturation defects in Btk-deficient B cells. To address this issue, we used 3-83 mu delta transgenic mice, which prematurely express a complete B cell receptor and therefore manifest accelerated B cell development. In Btk-deficient 3-83 mu delta mice, the IgM(+) B cells in the bone marrow exhibited a very immature phenotype (pre-BCR(+)CD43(+)CD2(-)) and were arrested at the transitional type 1 B cell stage upon arrival in the spleen. However, these cellular maturation defects were largely restored when Btk-deficient 3-83 mu delta B cells were on a centrally deleting background and therefore targeted for receptor editing. Providing an extended time window for developing B cells by enforced expression of the antiapoptotic gene Bcl-2 did not alter the Btk dependence of their cellular maturation. We conclude that premature B cell receptor expression amplifies the cellular maturation defects in Btk-deficient B cells, while extensive receptor editing reduces these defects.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Animals
  • B-Lymphocyte Subsets / enzymology
  • B-Lymphocyte Subsets / immunology
  • B-Lymphocyte Subsets / metabolism
  • B-Lymphocyte Subsets / pathology*
  • Cell Differentiation / genetics
  • Cell Differentiation / immunology
  • Cell Movement / genetics
  • Cell Movement / immunology
  • Cells, Cultured
  • Clonal Deletion / genetics
  • Down-Regulation / genetics
  • Down-Regulation / immunology*
  • Gene Rearrangement, B-Lymphocyte / genetics
  • Gene Rearrangement, B-Lymphocyte / immunology*
  • Hematopoietic Stem Cells / enzymology*
  • Hematopoietic Stem Cells / immunology
  • Hematopoietic Stem Cells / pathology
  • Immunoglobulin delta-Chains / genetics
  • Immunoglobulin kappa-Chains / biosynthesis
  • Immunoglobulin lambda-Chains / biosynthesis
  • Immunoglobulin mu-Chains / genetics
  • Lymphopenia / enzymology
  • Lymphopenia / genetics
  • Lymphopenia / immunology
  • Lymphopenia / pathology
  • Membrane Glycoproteins / biosynthesis*
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Pre-B Cell Receptors
  • Protein-Tyrosine Kinases / biosynthesis
  • Protein-Tyrosine Kinases / deficiency*
  • Protein-Tyrosine Kinases / genetics
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Receptors, Antigen, B-Cell / biosynthesis*
  • Receptors, Antigen, B-Cell / genetics
  • Spleen / immunology
  • Spleen / pathology
  • Up-Regulation / genetics
  • Up-Regulation / immunology*

Substances

  • Immunoglobulin delta-Chains
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Immunoglobulin mu-Chains
  • Membrane Glycoproteins
  • Pre-B Cell Receptors
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Antigen, B-Cell
  • Protein-Tyrosine Kinases
  • Agammaglobulinaemia Tyrosine Kinase
  • Btk protein, mouse